The burden of cancer-related neuropathic pain: A multi-centric cross-sectional observational study from North India
Open Access
- 1 January 2021
- journal article
- research article
- Published by Scientific Scholar in Indian Journal of Palliative Care
- Vol. 27 (1), 104-108
- https://doi.org/10.4103/ijpc.ijpc_277_20
Abstract
Introduction: Neuropathic cancer pain is a common consequence of cancer itself and anti-cancer treatments. It is a complex phenomenon, often underdiagnosed by physicians or underreported by patients. Its diagnosis and management are usually more challenging than nociceptive pain. There is a dearth of epidemiological evidence for neuropathic pain in cancer patients in India. Screening questionnaires serve as a quick guide to identify potential cases of neuropathic pain. The aim of the present study was to identify the burden of cancer-related neuropathic pain using the Self-reported version of the Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) pain scale. Methodology: This was a cross-sectional, observational, multi-centric study conducted at three hospitals in North India. From January 2017 to October 2017, patients attending pain clinic were screened for participation in the study. Adults aged ≥18 years and experiencing the pain of oncologic origin were eligible to participate in the study if they provided informed consent. S-LANSS questionnaire was used to screen patients with neuropathic pain. Results: From a total of 261 patients, who were enrolled in the study, 56.7% were male and their mean age was 50.87 (18–80) years. Fifty-four percent patients had pain with predominantly neuropathic component (S-LANSS score ≥10). Conclusion: High burden of neuropathic cancer pain has been observed in outpatient palliative care settings. Early diagnosis of neuropathic pain through screening questionnaires can serve as a quick guide for physicians in resource-constrained settings. This will allow identification of the neuropathic component of pain in patients suffering with mixed pain.Keywords
This publication has 28 references indexed in Scilit:
- Cancer-related neuropathic pain in out-patient oncology clinics: a European surveyBMC Palliative Care, 2013
- Neuropathic Pain in Cancer Patients—Prevalence and Management in a Tertiary Care Anesthesia-Run Referral Clinic Based in Urban IndiaJournal of Palliative Medicine, 2010
- Validity and Reliability of the Turkish Self-Administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) QuestionnairePain Medicine, 2010
- Types and Epidemiology of Cancer-Related Neuropathic Pain: The Intersection of Cancer Pain and Neuropathic PainThe Oncologist, 2010
- Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02Supportive Care in Cancer, 2009
- Prevalence, Etiology, and Management of Neuropathic Pain in an Indian Cancer HospitalJournal of Pain & Palliative Care Pharmacotherapy, 2009
- Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study)Supportive Care in Cancer, 2008
- A Questionnaire Survey of Physicians' Perspectives Regarding the Assessment of Chemotherapy-induced Peripheral Neuropathy in Patients with Breast CancerJapanese Journal of Clinical Oncology, 2008
- Can pain can be more or less neuropathic? Comparison of symptom assessment tools with ratings of certainty by cliniciansPain, 2006
- The S-LANSS score for identifying pain of predominantly neuropathic origin: Validation for use in clinical and postal researchThe Journal of Pain, 2005